Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem SA, succursale de Vionnaz
02 1Fermion Oy
03 1Teva API India Limited
04 1Assia Chemical Industries Ltd - Teva Tech Site
05 1Divi's Laboratories Limited
06 1Hetero Drugs Limited
07 1LETCO MEDICAL, LLC
08 1Maithri Drugs Private Limited
09 1Medisca Inc.
10 2Professional Compounding Centers of America dba PCCA
11 1Shandong Xinhua Pharmaceutical Co Ltd
12 1Spectrum Laboratory Products, Inc.
13 1Zhejiang Chiral Medicine Chemicals Co., Ltd.
01 3CARBIDOPA
02 1CARBIDOPA MONOHYDRATE
03 8Carbidopa
04 2carbidopa
01 2China
02 1Finland
03 3India
04 2Israel
05 1Switzerland
06 3U.S.A
07 2United Kingdom
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 51504-0001
Start Marketing Date : 1991-07-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
With Fermion, start the journey of your innovative API.
NDC Package Code : 12780-4420
Start Marketing Date : 2011-06-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
NDC Package Code : 15894-0040
Start Marketing Date : 2023-02-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62331-014
Start Marketing Date : 2004-03-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-2848
Start Marketing Date : 2010-10-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0202
Start Marketing Date : 2014-07-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-2480
Start Marketing Date : 2013-07-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0251
Start Marketing Date : 2022-10-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 58624-0621
Start Marketing Date : 1984-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-1692
Start Marketing Date : 1997-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
64
PharmaCompass offers a list of Carbidopa API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carbidopa manufacturer or Carbidopa supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carbidopa manufacturer or Carbidopa supplier.
PharmaCompass also assists you with knowing the Carbidopa API Price utilized in the formulation of products. Carbidopa API Price is not always fixed or binding as the Carbidopa Price is obtained through a variety of data sources. The Carbidopa Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid, including repackagers and relabelers. The FDA regulates alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid supplier is an individual or a company that provides alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid active pharmaceutical ingredient (API) or alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid finished formulations upon request. The alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid suppliers may include alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid API manufacturers, exporters, distributors and traders.
click here to find a list of alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid suppliers with NDC on PharmaCompass.
We have 13 companies offering alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid
Get in contact with the supplier of your choice:
